US FDA Issues Import Alert on Baddi Manufacturing Plant of Glenmark Pharmaceuticals
Glenmark Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has put its manufacturing plant located at Baddi, India, under import alert. The drugs manufactured at Glenmark Pharmaceuticals at Baddi plant can now be detained without any physical examination. The US FDA inspected the facility in June 2022, and has subsequently placed it […]
Continue Reading